239 related articles for article (PubMed ID: 35568790)
21. KEAP1/NRF2 axis regulates H
He J; Zhang X; Lian C; Wu J; Fang Y; Ye X
Gene; 2019 Apr; 691():8-17. PubMed ID: 30594636
[TBL] [Abstract][Full Text] [Related]
22. Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway.
Liu S; Pi J; Zhang Q
Redox Biol; 2022 Aug; 54():102389. PubMed ID: 35792437
[TBL] [Abstract][Full Text] [Related]
23. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway.
Baird L; Yamamoto M
Mol Cell Biol; 2020 Jun; 40(13):. PubMed ID: 32284348
[TBL] [Abstract][Full Text] [Related]
24. Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling.
Lee HH; Park SA; Almazari I; Kim EH; Na HK; Surh YJ
Arch Biochem Biophys; 2010 Sep; 501(1):142-50. PubMed ID: 20558128
[TBL] [Abstract][Full Text] [Related]
25. Mild ozonisation activates antioxidant cell response by the Keap1/Nrf2 dependent pathway.
Galiè M; Costanzo M; Nodari A; Boschi F; Calderan L; Mannucci S; Covi V; Tabaracci G; Malatesta M
Free Radic Biol Med; 2018 Aug; 124():114-121. PubMed ID: 29864481
[TBL] [Abstract][Full Text] [Related]
26. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
Nezu M; Suzuki N; Yamamoto M
Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
[TBL] [Abstract][Full Text] [Related]
27. Identification of an adaptor protein that facilitates Nrf2-Keap1 complex formation and modulates antioxidant response.
Zhang Y; Hou Y; Liu C; Li Y; Guo W; Wu JL; Xu D; You X; Pan Y; Chen Y
Free Radic Biol Med; 2016 Aug; 97():38-49. PubMed ID: 27212020
[TBL] [Abstract][Full Text] [Related]
28. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
[TBL] [Abstract][Full Text] [Related]
29. Effect of Inducers and Inhibitors of the Keap1/Nrf2/ARE System on the Viability and Functional Activity of Model Neuronal-Like and Glial Cells.
Menshchikova EB; Chechushkov AV; Kozhin PM; Romakh LP; Serykh AE; Khrapova MV; Petrova ES; Kandalintseva NV
Bull Exp Biol Med; 2024 Jan; 176(3):332-337. PubMed ID: 38340195
[TBL] [Abstract][Full Text] [Related]
30. Punicalagin attenuates palmitate-induced lipotoxicity in HepG2 cells by activating the Keap1-Nrf2 antioxidant defense system.
Yan C; Sun W; Wang X; Long J; Liu X; Feng Z; Liu J
Mol Nutr Food Res; 2016 May; 60(5):1139-49. PubMed ID: 26989875
[TBL] [Abstract][Full Text] [Related]
31. Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy.
Adelusi TI; Du L; Hao M; Zhou X; Xuan Q; Apu C; Sun Y; Lu Q; Yin X
Biomed Pharmacother; 2020 Mar; 123():109732. PubMed ID: 31945695
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-200a improves diabetic endothelial dysfunction by targeting KEAP1/NRF2.
Jiang Z; Wu J; Ma F; Jiang J; Xu L; Du L; Huang W; Wang Z; Jia Y; Lu L; Wu H
J Endocrinol; 2020 Apr; 245(1):129-140. PubMed ID: 32031966
[TBL] [Abstract][Full Text] [Related]
33. NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse model.
Moretti D; Tambone S; Cerretani M; Fezzardi P; Missineo A; Sherman LT; Munoz-Sajuan I; Harper S; Dominquez C; Pacifici R; Tomei L; Park L; Bresciani A
Free Radic Biol Med; 2021 Jan; 162():243-254. PubMed ID: 33096251
[TBL] [Abstract][Full Text] [Related]
34. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
Zgorzynska E; Dziedzic B; Walczewska A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
[TBL] [Abstract][Full Text] [Related]
35. Expression of Nrf2-Keap1-ARE signal pathway in traumatic lung injury and functional study.
Hu LY; Cui JB; Xu XM; Huang ZH; Jiao HT
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1402-1408. PubMed ID: 29565500
[TBL] [Abstract][Full Text] [Related]
36.
Nabeshima T; Hamada S; Taguchi K; Tanaka Y; Matsumoto R; Yamamoto M; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G419-G427. PubMed ID: 31961719
[TBL] [Abstract][Full Text] [Related]
37. Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress.
Suzuki T; Yamamoto M
J Biol Chem; 2017 Oct; 292(41):16817-16824. PubMed ID: 28842501
[TBL] [Abstract][Full Text] [Related]
38. Keap1-Nrf2 signaling pathway in angiogenesis and vascular diseases.
Guo Z; Mo Z
J Tissue Eng Regen Med; 2020 Jun; 14(6):869-883. PubMed ID: 32336035
[TBL] [Abstract][Full Text] [Related]
39. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
Chen CS; Tseng YT; Hsu YY; Lo YC
Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
[TBL] [Abstract][Full Text] [Related]
40. New insights into the mechanism of Keap1-Nrf2 interaction based on cancer-associated mutations.
Cheng L; Wang H; Li S; Liu Z; Wang C
Life Sci; 2021 Oct; 282():119791. PubMed ID: 34229009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
